Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma

Clinical Orthopaedics and Related Research

Volumn 341, Issue , 1997, Pages 192-205

  Papagelopoulos, Panayiotis J ^a   Galanis, Evanthia C ^a   Greipp, Philip R ^a   Sim, Franklin H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; MYELOMA; OSTEOSYNTHESIS; PATHOLOGIC FRACTURE; PATIENT CARE; PERIOPERATIVE PERIOD; PLASMACYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

EID: 0030761548     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199708000-00029     Document Type: Article

References (50)

1. Behr JT, Dobozi WR, Badrinath K: The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly. Clin Orthop 198:173-178, 1985.
2. Bergsagel DE: Chemotherapy of Myeloma. In Malpas JS, Bergsagel DE, Kyle RA (eds). Myeloma: Biology and Management. New York, Oxford University Press 273-306, 1995.
3. Brooker AF, Bowerman JW, Robinson RA, Riley Jr LH: Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg 55A:1629-1632, 1973.
4. Chandler HP, Penenberg BL: Bone Stock Deficiency in Total Hip Replacement: Classification and Management. Thorofare, NJ, Slack Incorporated 1989.
5. DeLee JG, Charnley J: Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop 121:20-32, 1976.
6. Dimopoulos MA, Goldstein J, Fuller L, Delasalle K, Alexanian R: Curability of solitary bone plasmacytoma. J Clin Oncol 10:587-590, 1992.
7. Durie BG: Staging and kinetics of multiple myeloma. Semin Oncol 13:300-309, 1986.
8. Durie BG, Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842-854, 1975.
9. Fielding JW, Cochran GV, Zickel RE: Biomechanical characteristics and surgical management of subtrochanteric fractures. Orthop Clin North Am 5:629-650, 1974.
10. Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA: Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 16:43-48, 1989.
11. Frassica FJ, Beabout JW, Unni KK, Sim FH: Myeloma of bone. Orthopedics 8:1184-1186, 1985.
12. Ganjoo RK, Malpas JS: Plasmacytoma. In Malpas JS, Bergsagel DE, Kyle RA (eds). Myeloma: Biology and Management. New York, Oxford University Press 463-476, 1995.
13. Griffiths DL: Orthopaedic aspects of myelomatosis. J Bone Joint Surg 48B:703-728, 1966.
14. Gruen TA, McNeice GM, Amstutz HC: 'Modes of failure' of cemented stem-type femoral components: A radiographic analysis of loosening. Clin Orthop 141:17-27, 1979.
15. Habermann ET, Sachs R, Stern RE, Hirsh DM, Anderson Jr WJ: The pathology and treatment of metastatic disease of the femur. Clin Orthop 169:70-82, 1982.
16. Harrington KD: The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg 63A:653-664, 1981.
17. Harrington KD: New trends in the management of lower extremity metastases. Clin Orthop 169:53-61, 1982.
18. Harrington KD: Orthopaedic management of extremity and pelvic lesions. Clin Orthop 312: 136-147, 1995.
19. Harrington KD, Sim FH, Enis JE, et al: Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J Bone Joint Surg 58A:1047-1055, 1976.
20. Johnson Jr EW: Intramedullary fixation of pathological fractures. JAMA 163:417-419, 1957.
21. Johnson JT: Reconstruction of the pelvic ring following tumor resection. J Bone Joint Surg 60A: 747-751, 1978.
22. Kahler O: Zur Symptomatologie des Multiplen Myeloms; Beobachtung von Albumosurie. Prag Med Wochenschr 14:33-45, 1889.
23. Khong KS, Chao EYS, Sim FH: Long-term performance of custom prosthetic replacement for neoplastic disease of the proximal femur. Proceedings of the 4th International Symposium on Limb Salvage. Kyoto, Japan 403-411, 1987.
24. Kyle RA: Myeloma and Related Disorders. In Wiernik PH, Canellos GP, Kyle RA, Schiffer CA (eds). Neoplastic Diseases of the Blood. New York, Churchill Livingstone 325-571, 1991.
25. Kyle RA, Elveback LR: Management and prognosis of multiple myeloma. Mayo Clin Proc 51:751-760, 1976.
26. Kyle RA, Jowsey J, Kelly PJ, Taves DR: Multiple-myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo. N Engl J Med 293:1334-1338, 1975.
27. Kyle RA, Schreiman JS, McLeod RA, Beabout JW: Computed tomography in diagnosis and management of multiple myeloma and its variants. Arch Intern Med 145:1451-1452, 1985.
28. Lane JM, Sculco TP, Zolan S: Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg 62A:954-959, 1980.
29. Levy RN, Sherry HS, Siffert RS: Surgical management of metastatic disease of bone at the hip. Clin Orthop 169:62-69, 1982.
30. Libshitz HI, Malthouse SR, Cunningham D, MacVicar AD, Husband JE: Multiple myeloma: Appearance at MR imaging. Radiology 182:833-837, 1992.
31. Longo DL: Plasma Cell Disorders. In Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Kasper DL (eds). Harrison's Principles of Internal Medicine. Vol 2. Ed 13. New York, McGraw-Hill 1618-1625, 1994.
32. McMaster WC, Bradley G, Waugh TR: Blood pressure lowering effect of methylmethacrylate monomer. Potentiation by blood volume deficit. Clin Orthop 98:254-257, 1974.
33. Mickelson MR, Bonfiglio M: Pathological fractures in the proximal part of the femur treated by Zickelnail fixation. J Bone Joint Surg 58A:1067-1070, 1976.
34. Moehring HD: Closed flexible intramedullary fixation for pathologic lesions in long bones. Orthopedics 7:829-834, 1984.
35. Osgood EE: The survival time of patients with plasmocytic myeloma. Cancer Chemother Rep 9:1-10, 1960.
36. Resnick D: Plasma Cell Dyscrasias and Dysgammaglobulinemias. In Resnick D (ed). Diagnosis of Bone and Joint Disorders. Vol 4. Ed 3. Philadelphia, WB Saunders Company 2147-2189, 1995.
37. Rock MG: The Use of Bateman Bipolar Proximal Femoral Replacement in the Management of Proximal Femoral Metastatic Disease. In Enneking WF, Jenett EL (eds). Limb Salvage in Musculoskeletal Oncology. New York, Springer-Verlag 437-442, 1988.
38. Sangeorzan BJ, Ryan JR, Salciccioli GG: Prophylactic femoral stabilization with the Zickel nail by closed technique. J Bone Joint Surg 68A:991-999, 1986.
39. Schreiman JS, McLeod RA, Kyle RA, Beabout JW: Multiple myeloma: Evaluation by CT. Radiology 154:483-486, 1985.
40. Schurman DJ, Amstutz HC: Treatment of neoplastic subtrochanteric fracture. Six cases treated with the Zickel nail. Clin Orthop 97:108-113, 1973.
41. Sim FH: Lesions of the Pelvis and Hip. In Sim FH (ed). Diagnosis and Management of Metastatic Bone Disease: A Multidisciplinary Approach. New York, Raven Press 183-198, 1988.
42. Sim FH, Chao EYS: Hip salvage by proximal femoral replacement. J Bone Joint Surg 63A: 1228-1239, 1981.
43. Sim FH, Chao EYS: Segmental Prosthetic Replacement of the Hip and Knee. In Chao EYS, Ivins JC (eds). Tumor Prostheses for Bone and Joint Reconstruction: The Design and Application. New York, Thieme-Stratton 247-266, 1983.
44. Sim FH, Frassica FJ, Chao EYS: Orthopaedic management using new devices and prostheses. Clin Orthop 312:160-172, 1995.
45. Unni KK: Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. Ed 5. Philadelphia, Lippincott-Raven Publishers 225-236, 1996.
46. von Rustizky J: Multiples Myelom. Dtsch Z Chir 3:162-172, 1873.
47. Watson HK, Campbell Jr RD, Wade PA: Classification, treatment and complications of the adult subtrochanteric fracture. J Trauma 4:457-480, 1964.
48. Wilkins RM, Sim FH, Springfield DS: Metastatic disease of the femur. Orthopedics 15:621-630, 1992.
49. Yazawa Y, Frassica FJ, Chao EYS, et al: Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 251:213-219, 1990.
50. Zickel RE, Mouradian WH: Intramedullary fixation of pathological fractures and lesions of the subtrochanteric region of the femur. J Bone Joint Surg 58A:1061-1066, 1976.